Correction: A cancer vaccine with dendritic cells differentiated with GM-CSF and IFNα and pulsed with a squaric acid treated cell lysate improves T cell priming and tumor growth control in a mouse model
Bioimpacts, 9(1), 65-65; DOI:10.15171/bi.2019.08
Correction
Correction: A cancer vaccine with dendritic cells differentiated with GM-CSF and IFNα and pulsed with a squaric acid treated cell lysate improves T cell priming and tumor growth control in a mouse model
Ananda Mookerjee1$&, Michele Graciotti2$, Lana E. Kandalaft1,2,*
1
Ovarian Cancer Research Center, University of Pennsylvania, Philadelphia, USA
2
Ludwig Cancer Research Center, University of Lausanne, Lausanne, Switzerland; Department of Oncology, University Hospital of Lausanne, Lausanne, Switzerland
*Corresponding author: Lana E. Kandalaft, Email: lana.kandalaft@chuv.ch
&Currently at: Cardiovascular Research Center, Icahn School of Medicine, Mount Sinai, New York, USA
$ These authors equally contributed.
This corrects the article "A cancer vaccine with dendritic cells differentiated with GM-CSF and IFNα and pulsed with a squaric acid treated cell lysate improves T cell priming and tumor growth control in a mouse model" published on 2018: Volume 08, Issue 03, Pages 211-221.
Correction to: BioImpacts 10.15171/bi.2018.24, published on 2018: Volume 08, Issue 03
The original version of this article contained a typographical error in the spelling of the author Lana E. Kandalaft, which was incorrectly given as Lana Kandalaft. This has now been corrected in the PDF and HTML versions of the article.